Literature DB >> 12533083

Cyp46 (24S-cholesterol hydroxylase): a genetic risk factor for Alzheimer disease.

Benjamin Wolozin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12533083     DOI： 10.1001/archneur.60.1.16

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  11 in total

1.  CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary.

Authors:  Anna Juhász; Agnes Rimanóczy; Krisztina Boda; Gábor Vincze; Gyozo Szlávik; Marianna Zana; Annamária Bjelik; Magdolna Pákáski; Nikoletta Bódi; András Palotás; Zoltán Janka; János Kálmán
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

Review 2.  Alzheimer's disease--a dysfunction in cholesterol and lipid metabolism.

Authors:  Walter J Lukiw; Miguel Pappolla; Ricardo Palacios Pelaez; Nicolas G Bazan
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

3.  Cardiovascular dementia - a different perspective.

Authors:  Udhaya Kumari; Klaus Heese
Journal:  Open Biochem J       Date:  2010-03-26

Review 4.  Cyp46 polymorphisms in Alzheimer's disease: a review.

Authors:  Anália Nusya Medeiros Garcia; Maria Tereza Cartaxo Muniz; Hugo Rafael Souza e Silva; Helker Albuquerque da Silva; Luiz Athayde-Junior
Journal:  J Mol Neurosci       Date:  2009-08-25       Impact factor: 3.444

Review 5.  The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications.

Authors:  Qingguang Jiang; Michael Heneka; Gary E Landreth
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  [Cholesterol and statins in Alzheimer disease].

Authors:  Gerhard Ransmayr
Journal:  Wien Med Wochenschr       Date:  2003

7.  Apolipoprotein E and cholesterol in aging and disease in the brain.

Authors:  Elena Posse de Chaves; Vasanthy Narayanaswami
Journal:  Future Lipidol       Date:  2008-10

Review 8.  Cholesterol efflux as a critical component of Alzheimer's disease pathogenesis.

Authors:  G William Rebeck
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Stereoselective synthesis and NMR characterization of C-24 epimeric pairs of 24-alkyl oxysterols.

Authors:  Shoujiro Ogawa; Hiroaki Kawamoto; Takashi Mitsuma; Hiroki Fujimori; Tatsuya Higashi; Takashi Iida
Journal:  Lipids       Date:  2012-11-30       Impact factor: 1.880

Review 10.  Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.

Authors:  Angel Cedazo-Mínguez
Journal:  J Cell Mol Med       Date:  2007 Nov-Dec       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.